Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial.

Johannes ScheteligCornelia S LinkGernot StuhlerEva M WagnerMathias HänelGuido KobbeSebastian BöttcherKarl-Anton KreuzerJan M MiddekeKatja SockelRaphael TeipelMalte von BoninFriedrich StölzelMichael KramerStephan StilgenbauerMichael HallekMartin Bornhäusernull null

Published in: British journal of haematology (2018)

Keyphrases

stem cell transplantation
high dose
phase iii
study protocol
phase ii
clinical trial
nk cells
open label
randomized controlled trial
bone marrow